Lexicon Pharmaceuticals, Inc.LXRXNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -492.65% |
| Q2 2025 | 112.86% |
| Q1 2025 | 25.09% |
| Q4 2024 | 47.90% |
| Q3 2024 | -21.30% |
| Q2 2024 | -10.40% |
| Q1 2024 | 2.73% |
| Q4 2023 | 1.52% |
| Q3 2023 | -12.52% |
| Q2 2023 | -40.62% |
| Q1 2023 | -4.72% |
| Q4 2022 | -30.39% |
| Q3 2022 | 4.88% |
| Q2 2022 | -4.73% |
| Q1 2022 | 8.34% |
| Q4 2021 | -10.76% |
| Q3 2021 | -27.98% |
| Q2 2021 | 13.79% |
| Q1 2021 | -281.40% |
| Q4 2020 | -106.65% |
| Q3 2020 | 219.59% |
| Q2 2020 | -3.69% |
| Q1 2020 | -30.26% |
| Q4 2019 | -122.62% |
| Q3 2019 | 1082.21% |
| Q2 2019 | -5.60% |
| Q1 2019 | -29.89% |
| Q4 2018 | 39.00% |
| Q3 2018 | 20.73% |
| Q2 2018 | 17.51% |
| Q1 2018 | -48.27% |
| Q4 2017 | 7.63% |
| Q3 2017 | 12.37% |
| Q2 2017 | -0.48% |
| Q1 2017 | -7.63% |
| Q4 2016 | 9.98% |
| Q3 2016 | 5.50% |
| Q2 2016 | -9.26% |
| Q1 2016 | -140.21% |
| Q4 2015 | 345.88% |